文献速递瓣膜病与结构性心脏病心律失常心力衰竭与心肌病

心血管磁共振预测Ebstein畸形主要不良事件与房性心动过速

Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance.
PubMed 文献 · Heart · 2017-07-06

结果显示,CMR衍生的心室功能与容积指标与MACE及首次AT独立相关,提示CMR可用于此类患者的定期监测。

要点

  • CMR衍生的左右心室射血分数、左室每搏量指数和心脏指数与MACE风险独立相关。
  • CMR指标(右室射血分数、右/左室容积指数、三尖瓣隔瓣下移程度)可预测首次房性心动过速。
  • 房性心动过速常先于MACE发生,可能作为不良预后的早期标志。

核心结论

  • 在未修复Ebstein畸形的成人中,CMR衍生指标可提供关于MACE和首次房性心动过速的预后信息。
  • CMR或可纳入此类患者的定期监测方案。

主要发现

  • 随访期间发生MACE共6例;与MACE相关的CMR变量包括右室射血分数(HR 2.06,95%CI 1.168-3.623,p=0.012)、左室射血分数(HR 2.35,95%CI 1.348-4.082,p=0.003)、左室每搏量指数(HR 2.82,95%CI 1.212-7.092,p=0.028)和心脏指数(HR 1.71,95%CI 1.002-1.366,p=0.037),仅针对死亡分析时上述指标仍显著。
  • 房性心动过速病史(HR 11.16,95%CI 1.30-95.81,p=0.028)和纽约心功能分级>2(HR 7.66,95%CI 1.54-38.20,p=0.013)也与MACE相关;除一例外,房性心动过速均先于MACE发生(p=0.011)。
  • 首次房性心动过速发生17例(21.5%);相关CMR变量包括右室射血分数(HR 1.55,95%CI 1.103-2.160,p=0.011)、总右/左室容积指数(HR 1.18,95%CI 1.06-1.32,p=0.002)、右/左室舒张末期容积比(HR 1.55,95%CI 1.14-2.10,p=0.005)和隔瓣尖下移距离/左室总隔长(HR 1.03,95%CI 1.00-1.07,p=0.041);后两者联合可增强风险预测(HR 6.12,95%CI 1.67-22.56,p=0.007)。

临床怎么用

  • 对于未修复Ebstein畸形的成人患者,可考虑将CMR纳入定期随访以评估MACE和房性心动过速风险。
  • 关注CMR提示的右室射血分数降低、左室射血分数降低、左室每搏量指数降低、心脏指数降低及右/左室容积比增高等高危特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with Ebstein's anomaly of the tricuspid valve (EA) are at risk of tachyarrhythmia, congestive heart failure and sudden cardiac death. We sought to determine the value of cardiovascular magnetic resonance (CMR) for predicting these outcomes. METHODS: Seventy-nine consecutive adult patients (aged 37±15 years) with unrepaired EA underwent CMR and were followed prospectively for a median 3.4 (range 0.4-10.9) years for clinical outcomes, namely major adverse cardiovascular events (MACEs: sustained ventricular tachycardia/heart failure hospital admission/cardiac transplantation/death) and first-onset atrial tachyarrhythmia (AT). RESULTS: CMR-derived variables associated with MACE (n=6) were right ventricular (RV) or left ventricular (LV) ejection fraction (EF) (HR 2.06, 95% CI 1.168 to 3.623, p=0.012 and HR 2.35, 95% CI 1.348 to 4.082, p=0.003, respectively), LV stroke volume index (HR 2.82, 95% CI 1.212 to 7.092, p=0.028) and cardiac index (HR 1.71, 95% CI 1.002 to 1.366, p=0.037); all remained significant when tested solely for mortality. History of AT (HR 11.16, 95% CI 1.30 to 95.81, p=0.028) and New York Heart Association class >2 (HR 7.66, 95% CI 1.54 to 38.20, p=0.013) were also associated with MACE; AT preceded all but one MACE, suggesting its potential role as an early marker of adverse outcome (p=0.011).CMR variables associated with first-onset AT (n=17; 21.5%) included RVEF (HR 1.55, 95% CI 1.103 to 2.160, p=0.011), total R/L volume index (HR 1.18, 95% CI 1.06 to 1.32, p=0.002), RV/LV end diastolic volume ratio (HR 1.55, 95% CI 1.14 to 2.10, p=0.005) and apical septal leaflet displacement/total LV septal length (HR 1.03, 95% CI 1.00 to 1.07, p=0.041); the latter two combined enhanced risk prediction (HR 6.12, 95% CI 1.67 to 22.56, p=0.007). CONCLUSION: CMR-derived indices carry prognostic information regarding MACE and first-onset AT among adults with unrepaired EA. CMR may be included in the periodic surveillance of these patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rydman R, Shiina Y, Diller GP, et al. Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance. Heart. 2017. PMID: 28684436. doi:10.1136/heartjnl-2017-311274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。